ClaresaSharonLevetanMD

PubMed

• 55 citations
  Impact of Computer-Generated Personalized Goals on HbA 1c
  Claresa S. Levetan, Karen R. Dawn, David C. Robbins, Robert E. Ratner
  Diabetes Care. 2002-01-01
• 15 citations
  Distinctions between islet neogenesis and β‐cell replication: Implications for reversal of Type 1 and 2 diabetes
  Claresa S. Levetan
  Journal of Diabetes. 2010-06-01
• 220 citations
  Unrecognized Diabetes Among Hospitalized Patients
  Claresa S. Levetan, Maureen D. Passaro, Kathleen A. Jablonski, Mary E. Kass, Robert E. Ratner
  Diabetes Care. 1998-02-01

Journal Articles

• Islet Neogenesis Therapy from Endogenous Pancreatic Stem Cells without Transplantation: Will Type 1 and Type 2 Diabetes Soon be Diseases of the Past?  
  Levetan C, J Diabetes Treat, 1/1/2017
• Proposal for generating new beta cells in a muted immune environment for type 1 diabetes  
  Levetan C, Pozzilli P, Jovanovic L, Schatz D, Diabetes Metab Res Rev, 1/12/2013
• Distinctions between islet neogenesis and Beta-cell replication: Implications for reversal of Type 1 and 2 diabetes  
  Levetan C, Journal of Diabetes, 1/1/2010
• Impact of computer-generated personalized goals on cholesterol lowering  
  Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC, Value in Health, 1/1/2005
• Impact of computergenerated personalized goals on cholesterol lowering  
  Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC, Value Health, 1/1/2005
• Impact of pramlintide on glucose fluctuations and postprandial glucose and glucagon among intensively treated type 1 diabetes patients using insulin pumps  
  Levetan CS, Want L, Mudaliar S, Henry RR, Maggs DG, Weyer C, Kolterman OG, Diabetes Care, 1/1/2003
• Into the Mouths of Babes: The Diabetes Epidemic in Children  
  Levetan CS, Clinical Diabetes, 1/1/2002
• Should hemoglobin A1c be renamed?  
  Levetan CS, Endocrine Practice, 1/1/2002
• Impact of Computer-Generated Personalized Goals on Hemoglobin A1c  
  Levetan CS, Dawn KR, Robbins DC, Ratner RE, Diabetes Care, 1/1/2002
• Probing the Problems of Pregnancy  
  CS Levetan, Clinical Diabetes, 1/1/2002
• The Controversy of the Treatment of Critically Ill Patients with Thyroid Hormone  
  Stantos N, Levetan C, Burman KD, Wartofsky L, Clinical Endocrinology and Metabolism, 1/1/2001
• Hyperglycemia in the hospital: A matter of life and death  
  CS Levetan, Clinical Diabetes, 1/1/2001
• Diabetes Prevention: How About NOW?  
  Levetan CS, Clinical Diabetes, 1/1/2001
• The Value of the Clinical Endocrinologist in the New Millennium  
  Levetan CS, The Endocrinologist, 1/1/2001
• Effect of physician specialty on diabetic ketoacidosis by generalists and specialists  
  Levetan C, Ratner R, Jablonski K, Diabetes Care, 1/1/1999
• Monitoring to Prevent Diabetes Complications  
  Garber AJ, Levetan CS, Neahring J, Patient Care, 1/1/1998
• A 49-year-old man with acute myocardial injury and hyperglycemia: diagnosis and treatment-Case Studies  
  Levetan, CS, Clinical Diabetes, 1/1/1998
• Intensive insulin therapy improves survival after MI in diabetes myocardial infarction  
  Levetan, CS, Clinical Diabetes, 1/1/1998
• The Value of Insulin: Is there really any question?  
  Levetan, CS, Clinical Diabetes, 1/1/1998
• Acute Myocardial Injury and Hyperglycemia: Diagnosis and Treatment  
  Levetan, CS, Clinical Diabetes, 1/1/1998
• Health care outcomes of diabetic ketoacidosis by generalists and specialists  
  Levetan C, Ratner R, Jablonski K, Diabetes, 1/1/1997
• Characteristics of hospitalized patients with unrecognized diabetes  
  Levetan C, Dawn K, Ayala A, Ratner R, Diabetes, 1/1/1997
• The Economic Bottom Line on Preventive Diabetes Care  
  Levetan C, and Ratner R, Practical Diabetology, 1/1/1995
• Join now to see all

Abstracts/Posters

• Impact of pramlintide on glucose among intensively treated type 1 diabetes patients using insulin pumps.
  Levetan CS, Want L, Mudaliar S, Henry RR, Maggs DG, Weyer C, Kolterman OG, Diabetes, 1/1/2002
• Improved postprandial of pramlintide on insulin requirements and postprandial glucose and triglyceride concentrations among well-controlled patients with type 1 diabet...
  Levetan CS, Want L, Mudaliar S, Henry RR, Maggs DG, Weyer C, Kolterman OG, Diabetes, 1/1/2002
• Impact of Pramlintide on the Amplitude of Glycemic Excursions.
  Levetan CS, Want LL, Diabetes, 1/1/2001
• When Do Glucose Values Best Correlate with Hemoglobin A1c?
  Levetan DS, LM Jeng, Thornton KR, Want LL, Ratner RE, Diabetes, 1/1/2001
• Identifying postprandial Peaks Using Continuous Glucose Monitoring.
  Ratner RE, Jeng LM, Want LL, Levetan CS, Thornton KR, Diabetes, 1/1/2001
• Glycated Hemoglobin: 24 Hour Recall for its Different Names.
  Levetan CS, Dawn KR, Want LL, Christian CA, Zimmerman C, Magee MF, Diabetes, 1/1/2000
• Impact of Daily Diabetes Empowerment Calendar on Medicare Beneficiaries.
  Osborn MA, Waterman CM, Robbins SG, Shugart NK, Levetan CS, Diabetes, 1/1/2000
• Join now to see all